Europe, Middle East and Africa Gastrointestinal Drugs Market Research Report, by Drug Category (Acid Neutralizers, Laxatives and Antidiarrheal, Anti-inflammatory drugs), By Route of Administration (Oral, Parenteral, Rectal), By Disease Type (Gastroesophageal Reflux Disease, Inflammatory Bowel Disease), by end user (Hospital Pharmacies, Retail Pharmacies) - Forecast till 2030

TABLE OF CONTENTS
1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS & LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET, BY DRUG CATEGORY

5.1 ACID NEUTRALIZERS

5.1.1 ANTACIDS

5.1.2 H2 ANTAGONISTS

5.1.3 PROTON PUMP INHIBITORS

5.1.4 OTHERS

5.2 LAXATIVES AND ANTIDIARRHEAL

5.3 ANTIEMETIC

5.4 ANTI-INFLAMMATORY DRUGS

5.5 OTHER

6. EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET, BY ROUTE OF ADMINISTRATION

6.1 ORAL

6.2 PARENTERAL

6.3 RECTAL

7. EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET, DISEASE TYPE

7.1 GASTROESOPHAGEAL REFLUX DISEASE

7.2 INFLAMMATORY BOWEL DISEASE

7.3 OTHER

8 EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET

8.1 HOSPITAL PHARMACIES

8.2 RETAIL PHARMACIES

8.3 OTHER

9. EUROPE, MIDDLE EAST AND AFRICA GASTROINTESTINAL DRUGS MARKET, BY REGION

9.1 INTRODUCTION

9.2 EUROPE

9.2.1 WESTERN EUROPE

9.2.1.1 GERMANY

9.2.1.2 FRANCE

9.2.1.3 ITALY

9.2.1.3 SPAIN

9.2.1.5 UK

9.2.1.6 REST OF WESTERN EUROPE

9.2.2 EASTERN EUROPE

9.3 MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

10.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS

10.1.1 STRATEGIC PARTNERSHIP

10.1.2 MERGER & ACQUISITION

11 COMPANY PROFILE

11.1 ABBVIE INC.

11.1.1 OVERVIEW

11.1.2 PRODUCT OVERVIEW

11.1.3 FINANCIALS

11.1.4 KEY DEVELOPMENTS

11.2 ASTRAZENECA

11.2.1 OVERVIEW

11.2.2 PRODUCT OVERVIEW

11.2.3 FINANCIALS

11.2.4 KEY DEVELOPMENTS

11.3 JOHNSON & JOHNSON

11.3.1 OVERVIEW

11.3.2 PRODUCT OVERVIEW

11.3.3 FINANCIALS

11.3.4 STRATEGY

11.3.5 KEY DEVELOPMENT

11.4 TAKEDA PHARMACEUTICAL COMPANY LIMITED

11.4.1 OVERVIEW

11.4.2 PRODUCT OVERVIEW

11.4.3 FINANCIALS

11.4.4 KEY DEVELOPMENTS

11.5 ALLERGAN PLC

11.5.1 OVERVIEW

11.5.2 PRODUCT OVERVIEW

11.5.3 FINANCIALS

11.5.4 KEY DEVELOPMENTS

11.6 OTHERS